Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M. Younossi, Victor Ankoma‐Sey, W Knapple et al.|The Lancet|2019Cited by 1.2k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Velimir A. Luketic, Juan F. Gallegos‐Orozco et al.|Gastroenterology|2016Cited by 1k
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosisRoberta D’Ambrosio, Pierre Bédossa, Alessio Aghemo et al.|Hepatology|2012Cited by 404
Liver extracellular matrix in health and diseasePierre Bédossa, Valérie Paradis|The Journal of Pathology|2003Cited by 299
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-upCorinne Castelnau, Elyanne Gault, Frédéric Le Gal et al.|Hepatology|2006Cited by 238